Shaler Alias - 04 Mar 2022 Form 4 Insider Report for Repay Holdings Corp (RPAY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Mar 2022, 16:00:49 UTC
Prior SEC filing
25 Feb 2022
Next SEC filing
15 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Timothy J. Murphy, as Attorney-in-Fact

Key filing fact

Shaler Alias filed Form 4 for Repay Holdings Corp (RPAY) on 04 Mar 2022.

Key facts

  • This page summarizes Shaler Alias's Form 4 filing for Repay Holdings Corp (RPAY).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Mar 2022, 16:00.

Change

  • Previous filing in this sequence was filed on 25 Feb 2022.
  • Current net transaction value: -$30,695.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RPAY transaction

Class A Common Stock

Tax liability

Transaction value
$30,695
Shares
-1,752
Change %
-0.5%
Price
$17.52*
Shares after
349,748
Date
04 Mar 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects shares of Class A common stock of the Issuer withheld to cover the Reporting Person's tax liability in connection with the vesting of shares of time-based restricted stock previously reported by the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .